Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.8080
-0.0300 (-3.58%)
Aug 21, 2026, 5:35 PM CET

Transgene Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.217.216.357.910.3417.24
Revenue Growth
-4.82%13.49%-19.58%-23.63%-40.00%80.08%
Gross Profit
-26.69-26.69-27.93-21.69-21.82-15.64
Operating Income
-35.06-35.06-35.66-30.01-29.9-23.7
Net Income
-37.52-37.52-33.97-22.33-32.8-19.54
Earnings Per Share
-0.26-0.26-0.29-0.22-0.33-0.21
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
111.86111.8616.6715.6726.8349.57
Total Debt
2.062.0610.417.313.5216.64
Net Cash (Debt)
109.8109.86.27-1.6313.3132.93
Net Cash Growth
-1650.06%---59.59%312.18%
Net Cash Per Share
0.760.760.05-0.020.130.36

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-37.05-37.05-23.55-34.67-20.3-25.91
Capital Expenditures
-0.84-0.84-3.07-2.67-1.5-0.67
Free Cash Flow
-37.89-37.89-26.61-37.34-21.8-26.58
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----274.53%-210.98%-90.75%
Operating Margin
-486.25%-486.25%-561.23%-379.90%-289.04%-137.45%
Pretax Margin
-520.44%-520.44%-534.72%-282.63%-317.13%-113.32%
Profit Margin
-520.44%-520.44%-534.72%-282.63%-317.13%-113.32%
FCF Margin
-525.49%-525.49%-418.92%-472.63%-210.75%-154.19%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-10.0410.0410.0410.0410.04
PS Ratio
30.6936.4614.1317.4415.9314.38